To the Editor: Skin disease often impairs quality of life and results in an increase in years lived with disability (YLDs). In 2010, skin disease was the fourth cause of nonfatal disease burden worldwide.1 Skin conditions ranked between the second and eleventh leading causes of YLDs globally.1 We investigated changes in the global burden of skin disease experienced in developed and developing countries between 1990 and 2013.
We used the Institute for Health Metrics and Evaluation (IHME) reports of Leading Causes of YLDs, 1990 and 2013.2 The percent change in skin diseases between 1990 and 2013 was collected for each country listed. Of the 187 reported countries, we identified 47 developed countries according to the 2015 Human Development Index.3 The greatest improvements were seen in Portugal, with a 9% decrease in disability between 1990 and 2013. Israel, Spain, the Czech Republic, and Hungary followed the lead with a 7% decrease in YLDs. In addition, 6 of the 47 developed countries did not see any changes in YLDs from skin conditions, and 11 experienced an increase in their YLDs (Fig 1). The mean percent change seen in developed countries was a 1.85% improvement in disability (standard deviation [SD] = 3.73 [95% confidence interval {CI}, −2.92 to −0.78]).
Of the 140 developing countries, 26 reported improvements in YLDs from skin diseases, as indicated by a negative percent change from 1990 to 2013 (Fig 2). The average percent change in developing countries was a 2.6% decrease in disability (SD = 3.75 [95% CI, 2.04-3.29]). Ten countries saw no change, and the majority of developing countries (n = 104) experienced an increase in disability. Nicaragua, Oman, and Palestine saw the greatest increase in percent change of disability (11%, 11%, and 15%, respectively).
Skin diseases continue to affect not only those living in developing countries, but also those living in developed countries. The decrease experienced in the United States was low (1%), especially when compared to other developed countries. In other words, the percentage of Americans living in less than ideal health because of skin diseases has not changed substantially in the past 23 years, even though the United States has been spending far more on health care than any other developed country.4
An increase in life expectancy of Americans may partially account for a larger number of people living in the United States with skin diseases. Yet most of the developed countries have also experienced an increase in life expectancy. This therefore does not fully explain why the United States lags behind the majority of developed countries in terms of improvements in disability from skin disease. In addition, Americans may have higher expectations regarding treatment of skin diseases as a result of direct-to-consumer pharmaceutical advertising, which may overemphasize potential benefits of medications.5 Patient expectations are unaccounted for in the IHME data.
Over the past 2 decades, the majority of both developed and developing countries have experienced little or no improvement in disability caused by skin diseases. Health care providers around the world must shift their focus to improving the quality of lives in their patients with skin diseases.
Footnotes
Ms Mounessa and Dr Braunberger contributed equally to this article.
Funding sources: The Bill and Melinda Gates Foundation.
Conflicts of interest: None declared.
Appendix. Abbreviations used:
Poland – POL
Taiwan – TWN
Korea – KOR
Denmark – DNK
Finland – FIN
Greece – GRC
Italy – ITA
Luxembourg – LUX
Montenegro – MNE
The Netherlands – NLD
Slovakia – SVK
Australia – AUS
Cyprus – CYP
Japan – JPN
Latvia – LVA
Malta – MLT
Singapore – SGP
India – IND
Iran – IRN
Pakistan – PAK
Rwanda – RWA
Vietnam – VNM
Angola – AGO
Dominican Republic – DOM
Haiti – HTI
Malaysia – MYS
Maldives – MDV
Sao Tome and Principe – STP
Swaziland – SWZ
Thailand – THA
Uzbekistan – UZB
Zimbabwe – ZWB
Botswana – BWA
Costa Rica – CRI
Democratic Republic of the Congo – RCB
El Salvador – SLV
Gabon – GAB
Laos – LAO
Lesotho – LSO
South Sudan – SSD
Tanzania – TZA
Central African Republic – CAF
Guinea – GIN
Indonesia – IDN
Lebanon – LBN
Mongolia – MNG
Mozambique – MOZ
Myanmar – MMR
South Africa – ZAF
Afghanistan – AFG
Albania – ALB
Azerbaijan – AZE
Congo – COG
Dominica – DMA
Equatorial Guinea – GNQ
Federated States of Micronesia – FSM
Honduras – HND
Jamaica – JAM
Kiribati – KIR
Liberia – LBR
Mauritius – MUS
Nigeria – NGA
Suriname – SUR
Togo – TGO
Trinidad and Tobago – TTO
Tunisia – TUN
Turkey – TUR
Uganda – UGA
Algeria – DZA
Barbados – BRB
Belize – BLZ
Bolivia – BOL
Burundi – BDI
China – CHN
Cote d'Ivoire – CIV
Eritrea – ERI
Malawi – MWI
Mexico – MEX
Morocco – MAR
Namibia – NAM
Philippines – PHL
Saint Vincent and the Grenadines – VCT
Senegal – SEN
Seychelles – SYC
Sri Lanka – LKA
Syria – SYR
Tajikistan – TJK
The Bahamas – BHS
Turkmenistan – TKM
Uruguay – URY
Armenia – ARM
Brazil – BRA
Chad – TCD
Colombia – COL
Cuba – CUB
Ethiopia – ETH
Guatemala – GTM
Moldova – MDA
Panama – PA
Papua New Guinea – PNG
Sierra Leone – SLE
Somalia – SOM
Timor-Leste – TLS
Antigua and Barbuda – ATG
Ecuador – ECU
Kyrgyzstan – KGZ
Madagascar – MDG
Marshall Islands – MHL
Mauritania – MRT
North Korea – PRK
Russia – RUS
Tonga – TON
Ukraine – UKR
Bosnia and Herzegovina – BIH
Cameroon – CMR
Comoros – COM
Iraq – IRQ
Jordan – JOR
Macedonia – MKD
Sudan – SDN
Belarus – BLR
Bulgaria – BGR
Djibouti – DJI
Kazakhstan – KAZ
Romania – ROU
Zambia – ZMB
References
- 1.Hay R.J., Johns N.E., Williams H.C. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–1534. doi: 10.1038/jid.2013.446. [DOI] [PubMed] [Google Scholar]
- 2.Institute for Health Metrics and Evaluation website. Country profiles. Available at: http://www.healthdata.org/results/country-profiles. Accessed May 24, 2016.
- 3.United Nations Development Programme website. Human development eports. Available at: http://hdr.undp.org/en/2015-report. Accessed May 24, 2016.
- 4.Squires D., Anderson C. U.S. health care from a global perspective: spending, use of services, prices, and health in 13 countries. Issue Brief (Commonw Fund) 2015;15:1–15. [PubMed] [Google Scholar]
- 5.Ventola C.L. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? P T. 2011;36:669–684. [PMC free article] [PubMed] [Google Scholar]